Double Medical Technology Inc
SZSE:002901

Watchlist Manager
Double Medical Technology Inc Logo
Double Medical Technology Inc
SZSE:002901
Watchlist
Price: 32.05 CNY -3.9% Market Closed
Market Cap: 13.3B CNY
Have any thoughts about
Double Medical Technology Inc?
Write Note

Double Medical Technology Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Double Medical Technology Inc
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Double Medical Technology Inc
SZSE:002901
Cash from Financing Activities
-ÂĄ57.2m
CAGR 3-Years
46%
CAGR 5-Years
20%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Cash from Financing Activities
-ÂĄ246.4m
CAGR 3-Years
-34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Cash from Financing Activities
-ÂĄ1.9B
CAGR 3-Years
N/A
CAGR 5-Years
-61%
CAGR 10-Years
N/A
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Cash from Financing Activities
-ÂĄ7B
CAGR 3-Years
-31%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Cash from Financing Activities
-ÂĄ863.5m
CAGR 3-Years
N/A
CAGR 5-Years
-34%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Cash from Financing Activities
-ÂĄ662.2m
CAGR 3-Years
20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Double Medical Technology Inc
Glance View

Market Cap
13.3B CNY
Industry
Health Care

Double Medical Technology, Inc. engages in production, research and development and sale of medical consumables. The company is headquartered in Xiamen, Fujian and currently employs 3,141 full-time employees. The company went IPO on 2017-09-22. The main products of the Company include orthopedic trauma implant materials, spinal implant materials and nerve surgical implant materials. Also, the Company manufactures surgical instruments. The firm distributes its products in domestic and overseas markets.

Intrinsic Value
31.35 CNY
Overvaluation 2%
Intrinsic Value
Price

See Also

What is Double Medical Technology Inc's Cash from Financing Activities?
Cash from Financing Activities
-57.2m CNY

Based on the financial report for Jun 30, 2024, Double Medical Technology Inc's Cash from Financing Activities amounts to -57.2m CNY.

What is Double Medical Technology Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
20%

The average annual Cash from Financing Activities growth rates for Double Medical Technology Inc have been 46% over the past three years , 20% over the past five years .

Back to Top